Tennessee HB 2246: Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.

Status: Pub. Ch. 1016 (as of 2026-05-26)

State: Tennessee · Session: 114 · Bill: HB 2246

Subjects: Health Care

Sponsors: Hurt

View Tennessee HB 2246 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.